Department of Neurosurgery, RWTH Aachen University, Aachen, Germany.
Program for Hospital and Intensive Care Informatics, Department of Neurology, Columbia University, New York, NY.
Crit Care Med. 2022 Feb 1;50(2):183-191. doi: 10.1097/CCM.0000000000005396.
The recommendation of induced hypertension for delayed cerebral ischemia treatment after aneurysmal subarachnoid hemorrhage has been challenged recently and ideal pressure targets are missing. A new concept advocates an individual cerebral perfusion pressure where cerebral autoregulation functions best to ensure optimal global perfusion. We characterized optimal cerebral perfusion pressure at time of delayed cerebral ischemia and tested the conformity of induced hypertension with this target value.
Retrospective analysis of prospectively collected data.
University hospital neurocritical care unit.
Thirty-nine aneurysmal subarachnoid hemorrhage patients with invasive neuromonitoring (20 with delayed cerebral ischemia, 19 without delayed cerebral ischemia).
Induced hypertension greater than 180 mm Hg systolic blood pressure.
Changepoint analysis was used to calculate significant changes in cerebral perfusion pressure, optimal cerebral perfusion pressure, and the difference of cerebral perfusion pressure and optimal cerebral perfusion pressure 48 hours before delayed cerebral ischemia diagnosis. Optimal cerebral perfusion pressure increased 30 hours before the onset of delayed cerebral ischemia from 82.8 ± 12.5 to 86.3 ± 11.4 mm Hg (p < 0.05). Three hours before delayed cerebral ischemia, a changepoint was also found in the difference of cerebral perfusion pressure and optimal cerebral perfusion pressure (decrease from -0.2 ± 11.2 to -7.7 ± 7.6 mm Hg; p < 0.05) with a corresponding increase in pressure reactivity index (0.09 ± 0.33 to 0.19 ± 0.37; p < 0.05). Cerebral perfusion pressure at time of delayed cerebral ischemia was lower than in patients without delayed cerebral ischemia in a comparable time frame (cerebral perfusion pressure delayed cerebral ischemia 81.4 ± 8.3 mm Hg, no delayed cerebral ischemia 90.4 ± 10.5 mm Hg; p < 0.05). Inducing hypertension resulted in a cerebral perfusion pressure above optimal cerebral perfusion pressure (+12.4 ± 8.3 mm Hg; p < 0.0001). Treatment response (improvement of delayed cerebral ischemia: induced hypertension+ [n = 15] or progression of delayed cerebral ischemia: induced hypertension- [n = 5]) did not correlate to either absolute values of cerebral perfusion pressure or optimal cerebral perfusion pressure, nor the resulting difference (cerebral perfusion pressure [p = 0.69]; optimal cerebral perfusion pressure [p = 0.97]; and the difference of cerebral perfusion pressure and optimal cerebral perfusion pressure [p = 0.51]).
At the time of delayed cerebral ischemia occurrence, there is a significant discrepancy between cerebral perfusion pressure and optimal cerebral perfusion pressure with worsening of autoregulation, implying inadequate but identifiable individual perfusion. Standardized induction of hypertension resulted in cerebral perfusion pressures that exceeded individual optimal cerebral perfusion pressure in delayed cerebral ischemia patients. The potential benefit of individual blood pressure management guided by autoregulation-based optimal cerebral perfusion pressure should be explored in future intervention studies.
最近,人们对蛛网膜下腔出血后迟发性脑缺血治疗中诱导高血压的建议提出了质疑,并且理想的压力目标仍然缺失。一个新的概念提倡在最佳的脑自动调节功能下,存在一个个体脑灌注压,以确保最佳的全局灌注。本研究旨在明确迟发性脑缺血发生时的最佳脑灌注压,并检验诱导性高血压与该目标值的一致性。
前瞻性收集数据的回顾性分析。
大学医院神经重症监护病房。
39 例接受有创神经监测的蛛网膜下腔出血患者(20 例发生迟发性脑缺血,19 例未发生迟发性脑缺血)。
收缩压高于 180mmHg 的诱导性高血压。
使用 Changepoint 分析计算了 48 小时前发生迟发性脑缺血诊断前的脑灌注压、最佳脑灌注压以及脑灌注压和最佳脑灌注压差值的显著变化。从迟发性脑缺血发作前 30 小时开始,最佳脑灌注压从 82.8±12.5mmHg 增加到 86.3±11.4mmHg(p<0.05)。在迟发性脑缺血发生前 3 小时,脑灌注压和最佳脑灌注压差值也出现了一个变化点(从-0.2±11.2mmHg 降低至-7.7±7.6mmHg;p<0.05),同时压力反应性指数增加(从 0.09±0.33 增加至 0.19±0.37;p<0.05)。在可比的时间框架内,发生迟发性脑缺血时的脑灌注压低于未发生迟发性脑缺血的患者(迟发性脑缺血时的脑灌注压为 81.4±8.3mmHg,未发生迟发性脑缺血时的脑灌注压为 90.4±10.5mmHg;p<0.05)。诱导性高血压可使脑灌注压升高超过最佳脑灌注压(升高 12.4±8.3mmHg;p<0.0001)。治疗反应(改善:诱导性高血压+[n=15]或进展:诱导性高血压-[n=5])与脑灌注压或最佳脑灌注压的绝对值或由此产生的差值均无相关性(脑灌注压[p=0.69];最佳脑灌注压[p=0.97];脑灌注压和最佳脑灌注压差值[p=0.51])。
在迟发性脑缺血发生时,脑灌注压和最佳脑灌注压之间存在显著差异,表明自动调节功能恶化,存在不足但可识别的个体灌注不足。在迟发性脑缺血患者中,标准化诱导性高血压导致的脑灌注压超过了个体的最佳脑灌注压。基于自动调节的最佳脑灌注压指导的个体化血压管理的潜在益处,应在未来的干预研究中进行探索。